Bianca Weinstock-Guttman, Katelyn Kavak, Caila Vaughn, et al. Discontinuation of disease modifying therapies in stable MS patients is associated with disability progression regardless of age. AAN 2018, S8.008.
Erfelijke kinderkanker CMMRD beter herkennen en behandelen
jun 2025 | Leukemie, Lymfoom, Maag-darm-leveroncologie, Neuro-oncologie